We could not show any correlation between CLL cell surface expression of LFA-3 and classical CLL risk factors, despite a significantly higher expression of LFA-3 in CLL cells compared to normal B-cells from healthy donors (Figure 7A). The gene discussed is CD58; the disease is B-cell chronic lymphocytic leukemia.